CD44 in inflammation and metastasis

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Glycoconjugate Journal

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1018540610858PMID 9298694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis.

  2010cited by this paper
• expression of the cd44 variant isoforms 6 and 4/5 in breast cancer correlation with established prognostic parameters

  2009cited by this paper
• Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence

  2004cited by this paper
• Binding of ovarian cancer cells to immobilized hyaluronic acid

  1997cited by this paper
• Surface carbohydrates involved in the adhesive interactions of metastatic cells.

  1997cited by this paper
• In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.

  1996cited by this paper
• Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva

  1996cited by this paper
• Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.

  1996cited by this paper
• [Expression of CD44 isoforms--a new histopathologic parameter in colorectal carcinoma?].

  1996cited by this paper
• CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix.

  1996cited by this paper
• Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.

  1996cited by this paper
• CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma

  1996cited by this paper
• Expression of CD44 isoforms in human skin cancer.

  1996cited by this paper
• Expression of CD44 splice variants in human skin and epidermal tumours

  1996cited by this paper
• Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan

  1996cited by this paper
• Keratan Sulfate Modification of CD44 Modulates Adhesion to Hyaluronate (*)

  1996cited by this paper
• CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down‐regulated during proliferation and tumor de‐differentiation

  1996cited by this paper
• Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.

  1996cited by this paper
• CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway

  1996cited by this paper
• Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)

  1996cited by this paper
• O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.

  1996cited by this paper
• A Blood Group-related Polymorphism of CD44 Abolishes a Hyaluronan-binding Consensus Sequence without Preventing Hyaluronan Binding (*)

  1996cited by this paper
• CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.

  1996cited by this paper
• Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: correlation with prominent fibromyxoid stromal response.

  1996cited by this paper
• Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages

  1996cited by this paper
• Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis

  1996cited by this paper
• Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis.

  1996cited by this paper
• Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type.

  1995cited by this paper
• CD44 variant exon epitopes in primary breast cancer and length of survival.

  1995cited by this paper
• Monoclonal antibodies to CD44 and their influence on hyaluronan recognition

  1995cited by this paper
• Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons

  1995cited by this paper
• Selectin-carbohydrate interactions and the initiation of the inflammatory response.

  1995cited by this paper
• Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells

  1995cited by this paper
• Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine

  1995cited by this paper
• Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity

  1995cited by this paper
• N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.

  1995cited by this paper
• Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis.

  1995cited by this paper
• CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

  1995cited by this paper
• Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon

  1995cited by this paper
• High‐level Expression of the CD44 Variant Sharing Exon v10 in Renal Cancer

  1995cited by this paper
• Are CD44 variant isoforms involved in human tumour progression?

  1995cited by this paper
• CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas.

  1995cited by this paper
• Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.

  1995cited by this paper
• Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation

  1995cited by this paper
• Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion

  1995cited by this paper
• A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan

  1995cited by this paper
• Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis

  1995cited by this paper
• CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors.

  1995cited by this paper
• Prognostic value of CD44 splice variant expression in ovarian cancer.

  1995cited by this paper
• Splice variants of CD44 in human cervical cancer stage IB to IIB.

  1995cited by this paper
• CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation

  1995cited by this paper
• Glycosylation of CD44 negatively regulates its recognition of hyaluronan

  1995cited by this paper
• A novel ligand for CD44 is sulfated proteoglycan.

  1994cited by this paper
• Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.

  1994cited by this paper
• Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.

  1994cited by this paper
• Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.

  1994cited by this paper
• Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.

  1994cited by this paper
• A precise, rapid and sensitive in vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells.

  1994cited by this paper
• Expression of CD44 abnormal transcripts in human gastric carcinomas.

  1994cited by this paper
• Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.

  1994cited by this paper
• Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.

  1994cited by this paper
• Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells

  1994cited by this paper
• Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response

  1994cited by this paper
• Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.

  1994cited by this paper
• Expression of CD44 Variant Isoforms in Normal and Neoplastic Cells of the Lung

  1994cited by this paper
• Expression of CD44 in prostate cancer cells.

  1994cited by this paper
• Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development

  1994cited by this paper
• Expression and modulation of CD44 variant isoforms in humans

  1994cited by this paper
• The Significance of CD44 in Human Pancreatic Cancer: I. High Expression of CD44 in Human Pancreatic Adenocarcinoma

  1994cited by this paper
• Alternative splicing of CD44 pre-mRNA in human colorectal tumors.

  1994cited by this paper
• Expression of the CD44 adhesion molecule in primary and metastatic gynecologic malignancies and their cell lines

  1994cited by this paper
• A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.

  1993cited by this paper
• A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps

  1993cited by this paper
• Prevention of tumor metastasis formation by anti-variant CD44

  1993cited by this paper
• CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation

  1993cited by this paper
• Identification of hyaluronic acid binding sites in the extracellular domain of CD44

  1993cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ

  1993cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta.

  1993cited by this paper
• The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44.

  1993cited by this paper
• Glycoprotein CD44 expression and its association with survival in breast cancer.

  1993cited by this paper
• Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages.

  1993cited by this paper
• CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.

  1993cited by this paper
• Expression and function of the CD44 glycoprotein in melanoma cell lines

  1993cited by this paper
• Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.

  1993cited by this paper
• Splicing choice from ten variant exons establishes CD44 variability.

  1993cited by this paper
• Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.

  1993cited by this paper
• Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix

  1992cited by this paper
• Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

  1992cited by this paper
• CD44: the hyaluronan receptor.

  1992cited by this paper
• Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein

  1992cited by this paper
• A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion

  1992cited by this paper
• Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

  1992cited by this paper
• Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody

  1992cited by this paper
• Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate.

  1991cited by this paper
• Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44.

  1991cited by this paper
• Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages

  1991cited by this paper
• The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms.

  1991cited by this paper
• Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis.

  1991cited by this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cited by this paper
• CD44 is the principal cell surface receptor for hyaluronate.

  1990cited by this paper

• Transformative therapy in acute microbial-induced colitis with inflammation triggered micelles and combination therapies.

  2025cites this paper
• Hyaluronic Acid: A Powerful Biomolecule with Wide-Ranging Applications—A Comprehensive Review

  2023cites this paper
• Pathway analysis of spermidine anti-oxidative stress and inducing autophagy in granulosa cells of Sichuan white geese.

  2023cites this paper
• Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4)

  2023cites this paper
• The role of hyaluronic acid in the design and functionalization of nanoparticles for the treatment of colorectal cancer.

  2023cites this paper
• Synergistic combination therapy delivered via layer‐by‐layer nanoparticles induces solid tumor regression of ovarian cancer

  2022cites this paper
• Defining the Versican Interactome in Lung Health and Disease.

  2022cites this paper
• Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells

  2022cites this paper
• Osteopontin expression in the invasive front stroma of colorectal adenocarcinoma is associated with tumor budding and prognosis.

  2022cites this paper
• Pyruvate kinase M2 in chronic inflammations: a potpourri of crucial protein–protein interactions

  2021cites this paper
• Marine Polysaccharides as a Versatile Biomass for the Construction of Nano Drug Delivery Systems

  2021cites this paper
• A New Printable Alginate/Hyaluronic Acid/Gelatin Hydrogel Suitable for Biofabrication of In Vitro and In Vivo Metastatic Melanoma Models

  2021cites this paper
• Active targeting of cancer cells by CD44 binding peptide-functionalized oil core-based nanocapsules

  2021cites this paper
• CD44 and RHAMM expression patterns in the human developing lung

  2020cites this paper
• Activating NK- receptors, homing selectins and inhibitory Siglecs recognize EBOLA-GP and HPV-L1NK

  2020influential citation
• Structural impact due to PPQEE deletion in multiple cancer associated protein - Integrin αV: An In silico exploration

  2020cites this paper
• Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use

  2020cites this paper
• Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics

  2020cites this paper
• The role of hyaluronic acid and versican in the skin extracellular matrix

  2020cites this paper
• Renal-clearable hyaluronic acid functionalized NaGdF4 nanodots with enhanced tumor accumulation

  2020cites this paper
• Inflammatory Alteration of Human T Cells Exposed Continuously to Asbestos

  2018cites this paper
• Biomedical applications of nanofibrillar cellulose

  2018cites this paper
• Minocycline decreases CD36 and increases CD44 in LPS-induced microglia.

  2018cites this paper
• Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells.

  2018cites this paper
• A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin.

  2017cites this paper
• Inflammation and Cancer

  2017cites this paper
• Peptide ligand‐modified nanomedicines for targeting cells at the tumor microenvironment☆

  2017cites this paper
• Revisiting Boronate/Diol Complexation as a Double Stimulus-Responsive Bioconjugation.

  2017cites this paper
• 21 On the Role of Cell Surface Chondroitin Sulfates and Their Core Proteins in Breast Cancer Metastasis

  2017cites this paper
• Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via p38- and ERK1/2-MAPK Signalling Pathways

  2017cites this paper
• via activation of CD44 Negative regulation of epithelium-neutrophil interactions

  2016cites this paper
• The prognostic role of CD 44 v 6 in hepatocellular carcinoma : a meta-analysis

  2016cites this paper
• Inhibition of Gene Expression and Cancer Cell Migration by CD44v3/6-Targeted Polyion Complexes.

  2016cites this paper
• Catch bond interaction allows cells to attach to strongly hydrated interfaces.

  2016cites this paper
• Drug-delivery and multifunction possibilities of hypocrellin photosensitizers

  2015cites this paper
• CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.

  2015cites this paper
• Exploiting Biomarkers Assists in Degradation of Breast Cancer Cells and Reduces Extravasation

  2015cites this paper
• Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer

  2015cites this paper
• Cancer Microenvironment and Inflammation: Role of Hyaluronan

  2015cites this paper
• The Role of Ceramide in Metastatic Processes in Breast Cancer

  2015cites this paper
• Recombinant Enzymes - From Basic Science to Commercialization

  2015cites this paper
• Lysosomal Degradation of CD44 Mediates Ceramide Nanoliposome-induced Anoikis and Diminished Extravasation in Metastatic Carcinoma Cells*

  2015cites this paper
• Hyaluronan and its function as an unspecific regulator of cell-bound receptors.

  2015cites this paper
• Case Study: Recombinant Bromelain Selection

  2015cites this paper
• Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.

  2014cites this paper
• Photo-cured hyaluronic acid-based hydrogels containing growth and differentiation factor 5 (GDF-5) for bone tissue regeneration.

  2014cites this paper
• Hyaluronan Is Not a Ligand but a Regulator of Toll-Like Receptor Signaling in Mesangial Cells: Role of Extracellular Matrix in Innate Immunity

  2014cites this paper
• Binding of Hyaluronic Acid to Its CD 44 Receptor

  2014cites this paper
• Differences between healthy hematopoietic progenitors and leukemia cells with respect to CD44 mediated rolling versus adherence behavior on hyaluronic acid coated surfaces.

  2014cites this paper
• Hyaluronan: biosynthesis and signaling.

  2014cites this paper
• CD 44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions

  2014cites this paper
• RGD-Modified dendrimers for drug encapsulation and targeted inhibition of tumor cells

  2014cites this paper
• Ex vivo reprogramming of tumor-reactive immune cells from FVBN202 mice bearing lung metastatic mammary carcinoma: an immunotherapeutic opportunity revealed against recurrence

  2013cites this paper
• This information is current as Peripheral Blood Monocytes Inflammatory Mediators in Human CD14+ Hyaluronan Binding Induced by Role of Sulfation in CD44-Mediated

  2013cites this paper
• Systemic Effects of a Commercial Preparation of Chondroitin Sulfate, Hyaluronic Acid and Nacetyl-D-glucosamine When Administered Parenteral to Healthy Cats

  2013cites this paper
• Rearrangement in T Cells Signaling and Modulates Actin CD45 Down-Regulates Lck-Mediated CD44

  2013cites this paper
• Molecular Mechanisms of Circulating Tumor Cell Adhesion in Breast Cancer Metastasis

  2013cites this paper
• Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype.

  2013cites this paper
• Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.

  2012cites this paper
• HY ALURONAN BASED BIOMATERIAL FOR ANTIADHESION AND THERMOSENSITIVE HY ALURONAN LANTHANIDE COMPLEXES by HaoLi

  2012cites this paper
• Decrease of CD44-positive cells correlates with tumor response to chemotherapy in patients with gastrointestinal cancer.

  2012cites this paper
• Quantification of glycopeptides by multiple reaction monitoring liquid chromatography/tandem mass spectrometry.

  2012cites this paper
• The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering

  2012cites this paper
• Bioengineering the Lung : Molecules , Materials , Matrix , Morphology , and Mechanics Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension

  2012cites this paper
• The Liberation of CD44 Intracellular Domain Modulates Adenoviral Vector Transgene Expression*

  2012cites this paper
• Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen).

  2012cites this paper
• Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

  2012cites this paper
• Shear stress regulates adhesion and rolling of CD44+ leukemic and hematopoietic progenitor cells on hyaluronan.

  2011cites this paper
• CD44 as a Hematopoietic stem cell marker

  2011cites this paper
• Inflammation and tumor metastasis: recent progress: Inflammation and tumor metastasis: recent progress

  2011cites this paper
• On the Role of Cell Surface Chondroitin Sulfates and Their Core Proteins in Breast Cancer Metastasis

  2011cites this paper
• The Human Hyaluronan Synthase 2 (HAS2) Gene and Its Natural Antisense RNA Exhibit Coordinated Expression in the Renal Proximal Tubular Epithelial Cell♦

  2011cites this paper
• Immunolocalization of the hyaluronan receptor CD44 in the reproductive tract of the mare.

  2011cites this paper
• Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells

  2011cites this paper
• CD44 as a Hematopoietic stem cell

  2011cites this paper
• Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer

  2011cites this paper
• Role of tumour necrosis factor alpha stimulated Gene-6 in the regulation of peri-cellular hyaluronan assembly in renal proximal tubular epithelial cells

  2011cites this paper
• Inhibition of CD44 N- and O-linked glycosylation decreases endometrial cell lines attachment to peritoneal mesothelial cells.

  2011cites this paper
• Inflammatory Alterations of the Extracellular Matrix in the Tumor Microenvironment

  2011cites this paper
• Collagen in Cancer

  2010cites this paper
• IMMUNE RESPONSE TO SYNTHESIZED PNIPAM-BASED GRAFT HYDROGELS CONTAINING CHITOSAN AND HYALURONIC ACID

  2010cites this paper
• Engineering the Extracellular Environment: Strategies for Building 2D and 3D Cellular Structures

  2010cites this paper
• Neutrophil microdomains: linking heterocellular interactions with vascular injury

  2010cites this paper
• Induction of oocyte maturation by hyaluronan-CD44 interaction in pigs.

  2010cites this paper
• Characterisation of the molecular mechanism required for glucocorticoid augmentation of macrophage phagocytosis of apoptotic neutrophils

  2010cites this paper
• Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold

  2009cites this paper
• Hyaluronan stimulates mobilization of mature hematopoietic cells but not hematopoietic progenitors.

  2009cites this paper
• A role for the endothelial glycosaminoglycan hyaluronan in neutrophil recruitment by endothelial cells cultured for prolonged periods

  2009cites this paper
• Expression of CD44 in canine mammary tumours.

  2009cites this paper
• Allogeneic Bone Marrow Transplantation and Role of CD44 in T cell Maturation

  2008cites this paper
• Engineered Micro-Environments and Vibrational Culture Systems for Vocal Fold Tissue Engineering

  2008cites this paper
• Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.

  2008cites this paper
• Indole carboxamides inhibit bovine testes hyaluronidase at pH 7.0 and indole acetamides activate the enzyme at pH 3.5 by different mechanisms.

  2008cites this paper
• CD45 Down-Regulates Lck-Mediated CD44 Signaling and Modulates Actin Rearrangement in T Cells1

  2008cites this paper
• Tumour malignancy loss and cell differentiation are associated with induction of gef gene in human melanoma cells

  2008cites this paper
• Indole carboxamides inhibit bovine testes hyaluronidase at pH 7.0 and indole acetamides activate the enzyme at pH 3.5 by different mechanisms

  2008cites this paper
• Hyaluronan Induces Cell Death in Activated T Cells through CD441

  2008cites this paper
• Hyaluronan Biology and Regulation in Renal Tubular Epithelial Cells and its Role in Kidney Stone Disease

  2008cites this paper
• Scaffolds based on hyaluronan crosslinked with a polyaminoacid: Novel candidates for tissue engineering application.

  2008cites this paper
• CD 45 Down-Regulates Lck-Mediated CD 44 Signaling and Modulates Actin Rearrangement in T Cells 1

  2008cites this paper